Endpoints in stem cell trials in ischemic heart failure

Despite multimodal regimens and diverse treatment options alleviating disease symptoms, morbidity and mortality associated with advanced ischemic heart failure remain high. Recently, technological innovation has led to the development of regenerative therapeutic interventions aimed at halting or rev...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Stem Cell Res Ther
Autors principals: Banovic, Marko, Loncar, Zlatibor, Behfar, Atta, Vanderheyden, Marc, Beleslin, Branko, Zeiher, Andreas, Metra, Marco, Terzic, Andre, Bartunek, Jozef
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2015
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4552990/
https://ncbi.nlm.nih.gov/pubmed/26319401
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-015-0143-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars